We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$1.24B
AUM Growth
-$612M
Cap. Flow
-$654M
Cap. Flow %
-52.6%
Top 10 Hldgs %
19.67%
Holding
716
New
21
Increased
155
Reduced
258
Closed
281

Top Sells

Rank Stock Value
1
LECO icon
Lincoln Electric
LECO
+$12.9M
2
AZTA icon
Azenta
AZTA
+$7.28M
3
OII icon
Oceaneering
OII
+$4.55M
4
PSB
PS Business Parks, Inc.
PSB
+$4.04M
5
PLD icon
Prologis
PLD
+$3.99M

Sector Composition

Rank Sector Weight
1 Technology 28.58%
2 Healthcare 14.8%
3 Industrials 9.69%
4 Consumer Discretionary 5.64%
5 Consumer Staples 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLLS
126
Cellectis
CLLS
$285M
$1.44M 0.12%
92,534
+10,933
+13% +$195K
NLSN
127
DELISTED
Nielsen Holdings plc
NLSN
$1.42M 0.11%
62,855
-394
-0.6% -$9.52K
MOR
128
DELISTED
MorphoSys AG American Depositary Shares
MOR
$1.41M 0.11%
58,310
+3,041
+6% +$75.4K
DIS icon
129
Walt Disney
DIS
$181B
$1.4M 0.11%
10,044
-2,151
-18% -$285K
GE icon
130
GE Aerospace
GE
$384B
$1.4M 0.11%
26,786
+470
+2% +$23.1K
MCD icon
131
McDonald's
MCD
$195B
$1.36M 0.11%
6,553
-422
-6% -$83.6K
F icon
132
Ford
F
$55.7B
$1.36M 0.11%
132,688
-7,719
-5% -$76.1K
PSA icon
133
Public Storage
PSA
$61.3B
$1.34M 0.11%
5,625
-3,366
-37% -$772K
ATRA icon
134
Atara Biotherapeutics
ATRA
$76.1M
$1.32M 0.11%
2,636
+1,186
+82% +$837K
MRNA icon
135
Moderna
MRNA
$23.6B
$1.32M 0.11%
89,907
+7,592
+9% +$163K
JCI icon
136
Johnson Controls International
JCI
$92.2B
$1.3M 0.1%
31,473
+1,521
+5% +$58.5K
AAP icon
137
Advance Auto Parts
AAP
$3.49B
$1.3M 0.1%
8,421
+483
+6% +$78.4K
CPB icon
138
Campbell Soup
CPB
$6.87B
$1.3M 0.1%
32,365
+387
+1% +$15.2K
DOC icon
139
Healthpeak Properties
DOC
$14.8B
$1.29M 0.1%
40,214
-28,414
-41% -$883K
AMZN icon
140
Amazon
AMZN
$2.96T
$1.26M 0.1%
13,360
-3,940
-23% -$367K
HRB icon
141
H&R Block
HRB
$5.86B
$1.25M 0.1%
42,829
-94,113
-69% -$2.53M
OMC icon
142
Omnicom Group
OMC
$23.4B
$1.25M 0.1%
15,311
-31,821
-68% -$2.51M
MET icon
143
MetLife
MET
$62.4B
$1.25M 0.1%
25,231
-46,865
-65% -$2.2M
CNP icon
144
CenterPoint Energy
CNP
$26.8B
$1.24M 0.1%
43,136
-79,060
-65% -$2.36M
XRAY icon
145
Dentsply Sirona
XRAY
$2.43B
$1.23M 0.1%
21,099
+836
+4% +$44.9K
JPM icon
146
JPMorgan Chase
JPM
$950B
$1.22M 0.1%
10,925
+1,226
+13% +$135K
ORCL icon
147
Oracle
ORCL
$423B
$1.22M 0.1%
21,428
-1,987
-8% -$108K
TAP icon
148
Molson Coors Class B
TAP
$8.1B
$1.22M 0.1%
21,766
-36,952
-63% -$2.16M
HUM icon
149
Humana
HUM
$46.2B
$1.21M 0.1%
4,542
-685
-13% -$174K
HSY icon
150
Hershey
HSY
$36.6B
$1.18M 0.1%
8,819
-532
-6% -$67.6K

Similar funds

Vident Investment Advisory's Q2 2019 Portfolio in Review

As of Q2 2019, Vident Investment Advisory held 716 positions worth $1.24B, down 33% from $1.85B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Vident Investment Advisory withdrew a net $654M in Q2 2019, closing 281 positions and reducing 258 holdings. Its most notable exit was Lincoln Electric, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Omnicell worth $13.7M.

  • Vident Investment Advisory's largest Q2 2019 buy was Omnicell: 159,055 shares worth $13.7M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $10.1M increase.
  • Vident Investment Advisory's biggest Q2 2019 reduction was Azenta, cutting an estimated $7.28M.
  • Vident Investment Advisory fully exited Lincoln Electric in Q2 2019, selling an estimated $12.9M.
  • Vident Investment Advisory's ten largest holdings make up 20% of its $1.24B portfolio in Q2 2019.
  • Vident Investment Advisory opened 21 new positions and closed 281 in Q2 2019.
  • Vident Investment Advisory's portfolio value fell 33% quarter-over-quarter to $1.24B.

Based on Vident Investment Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.